Showing results (181-190 of 454) with videos related to
Sort By:
Pageof 46
Oncology|April 15, 2010
Clinical significance of PTEN and p-Akt co-expression in HER2-positive metastatic breast cancer patients treated with trastuzumab-based therapiesAlessandra Fabi, G Metro, A Di Benedetto, et al.Drug Design, Development and Therapy|December 8, 2015
Prospective study on nanoparticle albumin-bound paclitaxel in advanced breast cancer: clinical results and biological observations in taxane-pretreated patientsAlessandra Fabi, Diana Giannarelli, Paola Malaguti, et al.Journal of Alternative and Complementary Medicine (New York, N.Y.)|April 27, 2016
Searching for Evidence to Support the Use of Ginger in the Prevention of Chemotherapy-Induced Nausea and VomitingPaolo Bossi, Diego Cortinovis, Maria Cossu Rocca, et al.Frontiers in Oncology|October 17, 2022
The immersive experience of virtual reality during chemotherapy in patients with early breast and ovarian cancers: The patient's dream studyAlessandra Fabi, Luana Fotia, Federico Giuseppini, et al.Translational Psychiatry|April 11, 2026
Identification of an immune-metabolic biosignature linking depressive symptoms and breast cancer in a clinical populationLetizia Giona, Barbara Collacchi, Sara Capoccia, et al.Scientific Reports|September 22, 2021
Presence and biodistribution of perfluorooctanoic acid (PFOA) in Paracentrotus lividus highlight its potential application for environmental biomonitoringDario Savoca, Raffaella Melfi, Antonio Palumbo Piccionello, et al.Journal of Neuro-Oncology|August 16, 2008
End of life issues in brain tumor patientsAndrea Pace, Cherubino Di Lorenzo, Cherubino Di Lorenzo, et al.Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 7, 2023
Pattern of care of brain tumor patients in the last months of life: analysis of a cohort of 3045 patients in the last 10 yearsAndrea Pace, Valeria Belleudi, Antonio Tanzilli, et al.Cancer|July 23, 2003
Prolonged gemcitabine infusion in advanced non-small cell lung carcinoma: a randomized phase II study of two different schedules in combination with cisplatinAnna Ceribelli, Cesare Gridelli, Filippo De Marinis, et al.Cancer Chemotherapy and Pharmacology|December 12, 2007
Impact of celecoxib on capecitabine tolerability and activity in pretreated metastatic breast cancer: results of a phase II study with biomarker evaluationAlessandra Fabi, Giulio Metro, Paola Papaldo, et al.Pageof 46